Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
publishDate:"[2022 TO 2022]"
topic_facet:"Phase: Phase 2"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (122)
1
This is a multicentre Phase II trial evaluating different booster strategies in individuals already vaccinated against SARS-CoV-2. This trial allows testing of different booster strategies for comparative assessment of their immune responses and safety against SARS-CoV-2 and its variants. This study tests whether a 4th vaccination dose is needed and determines the optimal booster vaccination schedule for further evaluation in a phase III trial. : An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a 4th homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2 (EU-COVAT-2 BOOSTAVAC) - EU-COVAT-2 BOOSTAVAC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
clinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia : An open-label, randomized, parallel-controlled, phase II-IIIclinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia - Aesculus Hippocastanum L seed extract in Covid-19 patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
This is a multicentre Phase II trial evaluating different booster strategies in individuals already vaccinated against SARS-CoV-2. This trial allows testing of different booster strategies for comparative assessment of their immune responses and safety against SARS-CoV-2 and its variants. This study tests whether a 4th vaccination dose is needed and determines the optimal booster vaccination schedule for further evaluation in a phase III trial. : An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a 4th homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2 (EU-COVAT-2 BOOSTAVAC) - EU-COVAT-2 BOOSTAVAC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
clinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia : An open-label, randomized, parallel-controlled, phase II-IIIclinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia - Aesculus Hippocastanum L seed extract in Covid-19 patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Efficacy and safety of XAV-19 for the treatment of moderate COVID-19 : An international, placebo-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of 150 mg XAV-19 infusion, in patients with moderate COVID-19: the EUROXAV study - EUROXAV Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Efficacy and safety of XAV-19 for the treatment of moderate COVID-19 : An international, placebo-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of 150 mg XAV-19 infusion, in patients with moderate COVID-19: the EUROXAV study - EUROXAV Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on COVID-19 development in hospitalized patients infected with SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) : An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on COVID-19 development in hospitalized patients infected with SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) - Kinarus COVID-19 Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
A Phase 2/3 Randomized, Double blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID 19 : A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE) - ADG20-PREV-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Phase 2/3 Efficacy and Safety Study of PF-07321332/Ritonavir in Nonhospitalized Low-Risk Adult Participants With COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on COVID-19 development in hospitalized patients infected with SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) : An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on COVID-19 development in hospitalized patients infected with SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) - Kinarus COVID-19 Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2022-2022
Filter aufheben
Thema: Phase: Phase 2
Medienart
122
Aufsätze
122
E-Artikel
122
E-Ressourcen
Zeitschriftentitel
122
WHO International Clinical Trials Registry Plat...
Thema
122
610
Phase: Phase 2
122
Recruitment Status: Authorised-recruitment may ...
122
Study Type: Interventional
8
Medical Condition: Acute respiratory distress s...
8
Medical Condition: Coronavirus Disease 2019 (CO...
6
Medical Condition: Prevention of COVID-19 infec...
6
Medical Condition: Severe Acute Respiratory Syn...
6
Medical Condition: Severe COVID-19 MedDRA versi...
4
Medical Condition: Adult hospitalized patients ...
4
Medical Condition: COVID-19 development in hosp...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Moderate to severe coronavir...
4
Medical Condition: Protection against COVID-19 ...
4
Medical Condition: The prevention of symptomati...
2
Medical Condition: Assessment of clinical impro...
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: COVID-19 disease MedDRA vers...
2
Medical Condition: COVID-19 in hospitalized pat...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2022-2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
120
Englisch
2
Französisch
Haven't found what you're looking for?
Wird geladen...